Opening Hours : Open Daily : 7.30 am to 7.00 pm
  Contact : +662 252 3833





What is Lite IVF/ICSI?

Nowadays, IVF/ICSI is considered to be the most effective treatment for infertility with its important method of follicle stimulation.

To get the appropriate amount and size of the follicles, Follicle Stimulating Hormone (FSH) containing drugs are used to stimulate follicles to develop and mature.

Variety of Follicle Stimulating Hormone (FSH) containing drugs will be adjusted for each patient whose, in some cases, dosage could reach up to 3,000-4,000 units per cycle.

At present, there are many studies involving minimal ovarian stimulation for in vitro fertilization in poor response group of patients. What they found is that there is no difference in quality and quantity of follicles whether high or low dosage was used, which resulted in the same successful clinical pregnancy rate. Therefore, with lesser dosage of drugs, poor response patients will benefit from better well-being in both body and mind, and also from lower cost of medications.

Moreover, according to the Fertility Sterility medical journal, August 2015, in a group of patients with young age and normal response to Follicle Stimulating Hormone (FSH) containing drugs, the use of low dosage resulted in similar pregnancy rate around 40-70% as in usual dosage.

However, the amount of follicles will be lesser in low dosage users than average (the average is around 5-8 follicles).

There are no complications such as Ovarian Hyperstimulation Syndrome (OHSS) to be found.


Which patients will benefit from Lite ICSI?

  • Age less than 36 years old
  • Body mass index less than 29 kg/m2
  • Anti-Mullerian hormone (AMH) more than 5 ng/ml
  • No pathology nor surgery of pelvis

“Lite ICSI is like a lite yogurt with its soft, low calories which gives you a better well-being. There will be less pain, less cost, and more successful pregnancy rate for infertile patients.”


นพ. มานพ จันทนพันธ์

Dr. Manop Janthanaphan, MD.
(Obstetrician and Gynecologist Subspecialty in Reproductive Medicine)


Contact us for more information